117 related articles for article (PubMed ID: 10478806)
1. Prognostic value of serum hepatocyte growth factor in patients with acute coronary syndromes.
Sato T; Yoshinouchi T; Sugimoto T; Sakamoto T; Fujieda H; Murao S; Sato H; Ohe T
Jpn Circ J; 1999 Aug; 63(8):583-8. PubMed ID: 10478806
[TBL] [Abstract][Full Text] [Related]
2. [Changes of serum hepatocyte growth factor in coronary artery disease].
Suzuki H; Murakami M; Kondo T; Shibata M; Ezumi H; Okabayashi H; Yorozuya M; Makishima N; Hamazaki Y; Nakatani M; Namiki A; Katagiri T
J Cardiol; 2000 May; 35(5):319-24. PubMed ID: 10834175
[TBL] [Abstract][Full Text] [Related]
3. [Changes of serum hepatocyte growth factor before and after percutaneous coronary intervention in patients with unstable angina pectoris and significance there].
Wang NF; Tong GX; Li PZ; Zhang XW; Xu J; Wu GP; Jin JF; Zhou L; Ye XH; Yang JM; Pan H
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1411-3. PubMed ID: 17785064
[TBL] [Abstract][Full Text] [Related]
4. Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease.
Soeki T; Tamura Y; Shinohara H; Tanaka H; Bando K; Fukuda N
Heart Vessels; 2000; 15(3):105-11. PubMed ID: 11289497
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor production may be related to the inflammatory response in patients with acute myocardial infarction.
Shimada Y; Yoshiyama M; Jissho S; Kamimori K; Nakamura Y; Iida H; Takeuchi K; Yoshikawa J
Circ J; 2002 Mar; 66(3):253-6. PubMed ID: 11922273
[TBL] [Abstract][Full Text] [Related]
6. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction.
Matsumori A; Furukawa Y; Hashimoto T; Ono K; Shioi T; Okada M; Iwasaki A; Nishio R; Sasayama S
Biochem Biophys Res Commun; 1996 Apr; 221(2):391-5. PubMed ID: 8619866
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes.
Heeschen C; Dimmeler S; Hamm CW; Boersma E; Zeiher AM; Simoons ML;
Circulation; 2003 Feb; 107(4):524-30. PubMed ID: 12566361
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.
Liuzzo G; Biasucci LM; Gallimore JR; Grillo RL; Rebuzzi AG; Pepys MB; Maseri A
N Engl J Med; 1994 Aug; 331(7):417-24. PubMed ID: 7880233
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor(HGF): a new biochemical marker for acute myocardial infarction.
Sato T; Yoshinouchi T; Sakamoto T; Fujieda H; Murao S; Sato H; Kobayashi H; Ohe T
Heart Vessels; 1997; 12(5):241-6. PubMed ID: 9846810
[TBL] [Abstract][Full Text] [Related]
10. [Endothelin and big endothelin in coronary heart disease and acute coronary syndromes].
Borries M; Heins M; Fischer Y; Stiegler H; Schoebel FC; Reinauer H; Strauer BE; Leschke M
Z Kardiol; 1996 Oct; 85(10):761-7. PubMed ID: 9036701
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes.
Bayes-Genis A; Conover CA; Overgaard MT; Bailey KR; Christiansen M; Holmes DR; Virmani R; Oxvig C; Schwartz RS
N Engl J Med; 2001 Oct; 345(14):1022-9. PubMed ID: 11586954
[TBL] [Abstract][Full Text] [Related]
12. [Significance of hepatocyte growth factor measurement in patients with acute myocardial infarction].
Sato T; Yoshinouchi T; Sugimoto T; Sakamoto T; Fujieda H; Sato H; Murao S; Kobayashi H; Ohe T
J Cardiol; 1998 Aug; 32(2):77-82. PubMed ID: 9752615
[TBL] [Abstract][Full Text] [Related]
13. Serial changes in serum VEGF and HGF in patients with acute myocardial infarction.
Soeki T; Tamura Y; Shinohara H; Tanaka H; Bando K; Fukuda N
Cardiology; 2000; 93(3):168-74. PubMed ID: 10965088
[TBL] [Abstract][Full Text] [Related]
14. Activated clotting times in acute coronary syndromes and percutaneous transluminal coronary angioplasty.
Wilson JM; Dougherty KG; Ellis KO; Ferguson JJ
Cathet Cardiovasc Diagn; 1995 Jan; 34(1):1-5. PubMed ID: 7728844
[TBL] [Abstract][Full Text] [Related]
15. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris.
Bertinchant JP; Polge A; Ledermann B; Genet L; Fabbro-Peray P; Raczka F; Brunet J; Poirey S; Wittenberg O; Pernel I; Nigond J
Am J Cardiol; 1999 Jul; 84(1):51-7. PubMed ID: 10404851
[TBL] [Abstract][Full Text] [Related]
16. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina.
Jude B; Agraou B; McFadden EP; Susen S; Bauters C; Lepelley P; Vanhaesbroucke C; Devos P; Cosson A; Asseman P
Circulation; 1994 Oct; 90(4):1662-8. PubMed ID: 7923650
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome.
Malý M; Vojácek J; Hrabos V; Kvasnicka J; Salaj P; Durdil V
Physiol Res; 2003; 52(6):719-28. PubMed ID: 14640893
[TBL] [Abstract][Full Text] [Related]
18. Circulating hepatocyte growth factor as a marker of thrombus formation in unstable angina pectoris.
Matsumori A; Miyazaki S; Takano H; Ono K; Okada M; Miyamoto T; Nonogi H; Daikoku S; Mitsudo K; Matsunaga Y; Ohnishi T; Daikuhara Y; Sasayama S
Jpn Circ J; 2000 Oct; 64(10):805-7. PubMed ID: 11059627
[TBL] [Abstract][Full Text] [Related]
19. Immediate and follow-up results of the conservative coronary angioplasty strategy for unstable angina pectoris.
Stammen F; De Scheerder I; Glazier JJ; Van Lierde J; Vrolix M; Willems JL; De Geest H; Piessens J
Am J Cardiol; 1992 Jun; 69(19):1533-7. PubMed ID: 1598865
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein as a marker for acute coronary syndromes.
Mach F; Lovis C; Gaspoz JM; Unger PF; Bouillie M; Urban P; Rutishauser W
Eur Heart J; 1997 Dec; 18(12):1897-902. PubMed ID: 9447317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
